Table 3 Multivariable analysis for the change in maximum CCA-IMT.
Variable | Univariable | Multivariable | ||
---|---|---|---|---|
Regression coefficient | P value | Regression coefficient | P value | |
Age, per 10Â years | 0.004 | 0.62 | 0.021 | 0.03 |
Men | 0.009 | 0.69 | 0.013 | 0.56 |
Body mass index, kg/m2 | 0.004 | 0.11 | 0.004 | 0.06 |
Hypertension |  − 0.033 | 0.21 |  − 0.040 | 0.13 |
Diabetes | 0.016 | 0.34 | 0.020 | 0.25 |
Dyslipidemia |  − 0.005 | 0.78 |  − 0.005 | 0.77 |
Current smoking |  − 0.029 | 0.23 |  − 0.020 | 0.42 |
ASCVD | 0.017 | 0.31 | 0.035 | 0.06 |
eGFR, per 10Â ml/min/1.73 m2 | 0.005 | 0.38 | 0.010 | 0.15 |
Serum uric acid, mg/dl |  − 0.009 | 0.27 | 0.009 | 0.15 |
Log-hs-CRP, ng/ml |  − 0.001 | 0.88 |  − 0.006 | 0.37 |
Baseline mean CCA-IMT, mm |  − 0.012 |  < 0.001 |  − 0.015 |  < 0.001 |
Allocation to febuxostat group |  − 0.017 | 0.31 |  − 0.014 | 0.39 |